This is a Validated Antibody Database (VAD) review about human KLRG1, based on 33 published articles (read how Labome selects the articles), using KLRG1 antibody in all methods. It is aimed to help Labome visitors find the most suited KLRG1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KLRG1 synonym: 2F1; CLEC15A; MAFA; MAFA-2F1; MAFA-L; MAFA-LIKE

BioLegend
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; 1:100; loading ...; fig 4e
BioLegend KLRG1 antibody (Biolegend, 138411) was used in flow cytometry on mouse samples at 1:100 (fig 4e). Nat Commun (2021) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; 1:200; loading ...; fig s7b
BioLegend KLRG1 antibody (Biolegend, 2F1/KLRG1) was used in flow cytometry on mouse samples at 1:200 (fig s7b). Nat Commun (2021) ncbi
mouse monoclonal (14C2A07)
  • flow cytometry; human; loading ...
BioLegend KLRG1 antibody (BioLegend, 14C2A07) was used in flow cytometry on human samples . Aging Cell (2021) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend KLRG1 antibody (Biolegend, 138410) was used in flow cytometry on mouse samples (fig 2a). Cell Rep (2021) ncbi
mouse monoclonal (SA231A2)
  • flow cytometry; human; loading ...; fig 3a
BioLegend KLRG1 antibody (BioLegend, 367718) was used in flow cytometry on human samples (fig 3a). Immunity (2021) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; loading ...; fig 4e
BioLegend KLRG1 antibody (Biolegend, 138418) was used in flow cytometry on mouse samples (fig 4e). Cell Rep Med (2021) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; 1:200; loading ...; fig s8g
BioLegend KLRG1 antibody (BioLegend, 138417) was used in flow cytometry on mouse samples at 1:200 (fig s8g). Nature (2021) ncbi
mouse monoclonal (SA231A2)
  • other; mouse
BioLegend KLRG1 antibody (BioLegend, SA231A2) was used in other on mouse samples . Nat Commun (2020) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend KLRG1 antibody (BioLegend, 138429) was used in flow cytometry on mouse samples (fig s2a). Cell (2020) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; 1:100; loading ...; fig 6a, 6s1a
BioLegend KLRG1 antibody (Biolegend, 138417) was used in flow cytometry on mouse samples at 1:100 (fig 6a, 6s1a). elife (2020) ncbi
mouse monoclonal (14C2A07)
  • flow cytometry; human; fig 4d
BioLegend KLRG1 antibody (Biolegend, 14C2A07) was used in flow cytometry on human samples (fig 4d). J Immunother Cancer (2020) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend KLRG1 antibody (Biolegend, 2F1/KLRG1) was used in flow cytometry on mouse samples (fig 1a). BMC Immunol (2019) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; loading ...; fig s2d
BioLegend KLRG1 antibody (Biolegend, 138410) was used in flow cytometry on mouse samples (fig s2d). Cell Rep (2019) ncbi
mouse monoclonal (SA231A2)
  • flow cytometry; human; loading ...
BioLegend KLRG1 antibody (Biolegend, SA231A2) was used in flow cytometry on human samples . Front Immunol (2019) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; human; loading ...; fig 1b
BioLegend KLRG1 antibody (Biolegend, 138419) was used in flow cytometry on human samples (fig 1b). Cell Mol Gastroenterol Hepatol (2020) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; fig 3e
BioLegend KLRG1 antibody (BioLegend, 138416) was used in flow cytometry on mouse samples (fig 3e). Immunity (2019) ncbi
mouse monoclonal (14C2A07)
  • flow cytometry; human; loading ...; fig s1b
BioLegend KLRG1 antibody (BioLegend, 14C2A07) was used in flow cytometry on human samples (fig s1b). Eur J Immunol (2019) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend KLRG1 antibody (BioLegend, 138412) was used in flow cytometry on mouse samples (fig 1c). Cell (2019) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; loading ...; fig 3e
BioLegend KLRG1 antibody (BioLegend, 138416) was used in flow cytometry on mouse samples (fig 3e). Immunity (2018) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; loading ...; fig 3
BioLegend KLRG1 antibody (Biolegend, 138412) was used in flow cytometry on mouse samples (fig 3). Sci Rep (2017) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend KLRG1 antibody (BioLegend, 2F1/KLRG1) was used in flow cytometry on mouse samples (fig s1a). Nature (2017) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; loading ...; fig s7e
In order to find microenvironmental regulators of metastatic colonization, BioLegend KLRG1 antibody (Biolegend, 2F1/KLRG1) was used in flow cytometry on mouse samples (fig s7e). Nature (2017) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; fig 5b
BioLegend KLRG1 antibody (BioLegend, 2F1/KLRG1) was used in flow cytometry on mouse samples (fig 5b). Nat Commun (2016) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend KLRG1 antibody (BioLegend, 2F1/KLRG1) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2017) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; 1:100; fig s1a
In order to suggest that air-pollution-induced atopic dermatitis occurs through activation of AhR, BioLegend KLRG1 antibody (BioLegend, 2F1/KLRG1) was used in flow cytometry on mouse samples at 1:100 (fig s1a). Nat Immunol (2017) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; human; loading ...; fig 1b
BioLegend KLRG1 antibody (BioLegend, 2F1/KLRG1) was used in flow cytometry on human samples (fig 1b). Nat Immunol (2016) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; fig s13
In order to study the response of intestinal tuft cells to parasites, BioLegend KLRG1 antibody (Biolegend, 2F1/KLRG1) was used in flow cytometry on mouse samples (fig s13). Science (2016) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; fig 5
BioLegend KLRG1 antibody (Biolegend, 2F1) was used in flow cytometry on mouse samples (fig 5). Sci Rep (2016) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; fig 2a
BioLegend KLRG1 antibody (Biolegend, 2F1/KLRG1) was used in flow cytometry on mouse samples (fig 2a). J Immunol (2015) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse; fig 3c
In order to assess a CD 4 T-cell population during tuberculosis that has memory-like properties maintained by Bcl6 and ICOS-dependent pathways, BioLegend KLRG1 antibody (BioLegend, 2F1) was used in flow cytometry on mouse samples (fig 3c). J Exp Med (2015) ncbi
Syrian golden hamster monoclonal (2F1/KLRG1)
  • flow cytometry; mouse
BioLegend KLRG1 antibody (BioLegend, 2F1/KLRG1) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
Invitrogen
mouse monoclonal (13F12F2)
  • flow cytometry; human; 1:33; loading ...; fig 6d
Invitrogen KLRG1 antibody (Thermo Scientific, 13F12F2) was used in flow cytometry on human samples at 1:33 (fig 6d). Gastroenterology (2019) ncbi
Santa Cruz Biotechnology
hamsters monoclonal (2F1)
  • flow cytometry; mouse; fig s7b
Santa Cruz Biotechnology KLRG1 antibody (Santa Cruz, 2F1) was used in flow cytometry on mouse samples (fig s7b). Proc Natl Acad Sci U S A (2015) ncbi
Articles Reviewed
  1. Petley E, Koay H, Henderson M, Sek K, Todd K, Keam S, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12:4746 pubmed publisher
  2. Ercolano G, Gomez Cadena A, Dumauthioz N, Vanoni G, Kreutzfeldt M, Wyss T, et al. PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions. Nat Commun. 2021;12:2538 pubmed publisher
  3. Martínez Zamudio R, Dewald H, Vasilopoulos T, Gittens Williams L, Fitzgerald Bocarsly P, Herbig U. Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans. Aging Cell. 2021;20:e13344 pubmed publisher
  4. Kastenschmidt J, Coulis G, Farahat P, Pham P, Rios R, Cristal T, et al. A stromal progenitor and ILC2 niche promotes muscle eosinophilia and fibrosis-associated gene expression. Cell Rep. 2021;35:108997 pubmed publisher
  5. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  6. Bonilla W, Kirchhammer N, Marx A, Kallert S, Krzyzaniak M, Lu M, et al. Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack. Cell Rep Med. 2021;2:100209 pubmed publisher
  7. Bielecki P, Riesenfeld S, Hütter J, Torlai Triglia E, Kowalczyk M, Ricardo Gonzalez R, et al. Skin-resident innate lymphoid cells converge on a pathogenic effector state. Nature. 2021;592:128-132 pubmed publisher
  8. Tseng H, Xiong W, Badeti S, Yang Y, Ma M, Liu T, et al. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma. Nat Commun. 2020;11:4810 pubmed publisher
  9. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  10. Vacca F, Chauch C, Jamwal A, Hinchy E, Heieis G, Webster H, et al. A helminth-derived suppressor of ST2 blocks allergic responses. elife. 2020;9: pubmed publisher
  11. Marotte L, Simon S, Vignard V, Dupré E, Gantier M, Cruard J, et al. Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. J Immunother Cancer. 2020;8: pubmed publisher
  12. Mantani P, Dunér P, Ljungcrantz I, Nilsson J, Bjorkbacka H, Fredrikson G. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions. BMC Immunol. 2019;20:47 pubmed publisher
  13. Wang L, Shen E, Luo L, Rabe H, Wang Q, Yin J, et al. Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor. Cell Rep. 2019;29:1848-1861.e6 pubmed publisher
  14. Sanz Ortega L, Rojas J, Portilla Y, Pérez Yagüe S, Barber D. Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions. Front Immunol. 2019;10:2073 pubmed publisher
  15. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
  16. Wu J, Ma S, Sandhoff R, Ming Y, Hotz Wagenblatt A, Timmerman V, et al. Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness. Immunity. 2019;50:1218-1231.e5 pubmed publisher
  17. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed publisher
  18. Karimzadeh H, Kiraithe M, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze zur Wiesch J, et al. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level. Gastroenterology. 2019;156:1820-1833 pubmed publisher
  19. Kobayashi T, Voisin B, Kim D, Kennedy E, Jo J, Shih H, et al. Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium. Cell. 2019;176:982-997.e16 pubmed publisher
  20. Nadjsombati M, McGinty J, Lyons Cohen M, Jaffe J, DiPeso L, Schneider C, et al. Detection of Succinate by Intestinal Tuft Cells Triggers a Type 2 Innate Immune Circuit. Immunity. 2018;49:33-41.e7 pubmed publisher
  21. Glasner A, Isaacson B, Viukov S, Neuman T, Friedman N, Mandelboim M, et al. Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression. Sci Rep. 2017;7:13090 pubmed publisher
  22. Wallrapp A, Riesenfeld S, Burkett P, Abdulnour R, Nyman J, Dionne D, et al. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature. 2017;549:351-356 pubmed publisher
  23. van der Weyden L, Arends M, Campbell A, Bald T, Wardle Jones H, Griggs N, et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature. 2017;541:233-236 pubmed publisher
  24. Tripathi D, Venkatasubramanian S, Cheekatla S, Paidipally P, Welch E, Tvinnereim A, et al. A TLR9 agonist promotes IL-22-dependent pancreatic islet allograft survival in type 1 diabetic mice. Nat Commun. 2016;7:13896 pubmed publisher
  25. Ma C, Mishra S, Demel E, Liu Y, Zhang N. TGF-? Controls the Formation of Kidney-Resident T Cells via Promoting Effector T Cell Extravasation. J Immunol. 2017;198:749-756 pubmed publisher
  26. Hidaka T, Ogawa E, Kobayashi E, Suzuki T, Funayama R, Nagashima T, et al. The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin. Nat Immunol. 2017;18:64-73 pubmed publisher
  27. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed publisher
  28. Howitt M, Lavoie S, Michaud M, Blum A, Tran S, Weinstock J, et al. Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut. Science. 2016;351:1329-33 pubmed publisher
  29. Polansky J, Bahri R, Divivier M, Duitman E, Vock C, Goyeneche Patino D, et al. High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner. Sci Rep. 2016;6:19699 pubmed publisher
  30. Li Y, Shen C, Zhu B, Shi F, Eisen H, Chen J. Persistent Antigen and Prolonged AKT-mTORC1 Activation Underlie Memory CD8 T Cell Impairment in the Absence of CD4 T Cells. J Immunol. 2015;195:1591-8 pubmed publisher
  31. Weigelin B, Bolaños E, Teijeira A, Martinez Forero I, Labiano S, Azpilikueta A, et al. Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb. Proc Natl Acad Sci U S A. 2015;112:7551-6 pubmed publisher
  32. Moguche A, Shafiani S, Clemons C, Larson R, Dinh C, Higdon L, et al. ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis. J Exp Med. 2015;212:715-28 pubmed publisher
  33. White C, Villarino N, Sloan S, Ganusov V, Schmidt N. Plasmodium suppresses expansion of T cell responses to heterologous infections. J Immunol. 2015;194:697-708 pubmed publisher